Shares of Dr. Reddy's Laboratories Ltd. 500124 slipped 1.60% to 1,220.85 Indian rupees Monday, on what proved to be an all-around grim trading session for the stock market, with the BSE SENSEX Index 1 ...

Dr. Reddy's Laboratories Ltd. closed 12.64% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

An announcement from Dr Reddy’s Laboratories ( ($RDY) ) is now available. On February 4, 2025, Dr. Reddy’s Laboratories announced its ...

Dr. Reddy’s Laboratories has announced the sale of its wholly owned subsidiary, Dr. Reddy’s Laboratories Louisiana LLC, along with its manufacturing facility in Shreveport, Louisiana ...

Dr. Reddy’s Laboratories has announced the incorporation of a new wholly-owned subsidiary, Dr. Reddy’s Finland Oy, under its existing subsidiary, Dr. Reddy’s Laboratories SA, Switzerland.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active ...

Dr Reddy’s Laboratories’ net profit is likely to remain little lower or almost flat at around ₹1360-65 crore in the third quarter of the current fiscal ended December 2024 compared to ...

Crossmark Global Holdings Inc. grew its stake in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 328.3% in the fourth quarter, Holdings Channel reports. The firm owned 12,760 ...

Stock Market Today: Dr Reddy's Laboratories share price declined more than 6% in the morning trades on Friday post-Q3 results that were announced after the market hours of Thursday. On Thursday ...

As of 11:04 a.m., shares of Dr Reddy's Laboratories traded 1.65 per cent or Rs 99.5 higher, at Rs 6,147.1 apiece on BSE. The market capitalisation of the company at around the same time stood at Rs ...